Public-health bodies and non-profits at World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
38 public-health bodies and non-profits are at World Vaccine Congress 2027 — 32 presentations on the program and 3 with a booth in the exhibit hall. Most represented: CEPI (7 on the program), International Vaccine Institute (3 on the program), Americas Health Foundation (2 on the program). 5 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–19 of 38 organizations
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
CEPI Oslo, Norway | |
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats. | Talk Wed Mar 10 09:10 Panel Wed Mar 10 09:10 Talk Wed Mar 10 16:40 Deep Dive Session: Non-animal preclinical systems for vaccine development and pandemic preparedness How organoids and organ-on-chip systems could replace some animal studies in early vaccine testing and pandemic preparedness. |
International Vaccine Institute Seoul, South Korea | |
International non-profit organization developing and delivering vaccines for global health. | Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. Infectious disease & AMR |
Americas Health Foundation Washington, DC | |
Nonprofit that convenes experts to produce evidence and policy recommendations to widen healthcare access in Latin America. | Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. Supply, safety & accessInfectious disease & AMR |
Clinton Foundation New York, NY | |
Non-profit foundation running programs on global health, economic opportunity and climate. | Keynote Thu Mar 11 13:40 |
European Medicines Agency Amsterdam, Netherlands | |
The European Union's medicines regulator, evaluating and monitoring vaccines and medicines. | Keynote Tue Mar 9 15:50 Keynote Panel: The Speed vs. Certainty Paradox: Redefining the Threshold of Evidence for Next-Generation Approvals Whether regulators should keep demanding large late-stage trials or approve vaccines faster on immune markers and real-world safety data. Clinical & preclinical development |
Gavi, the Vaccine Alliance Geneva, Switzerland | |
Global vaccine alliance funding immunization and shaping vaccine markets for lower-income countries. | Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. Supply, safety & accessInfectious disease & AMR |
PATH Seattle, WA | |
Global health non-profit working on vaccine development, delivery and immunization systems in low- and middle-income countries. | Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. Infectious disease & AMR |
USDA Agricultural Research Service Beltsville, MD | |
Research agency of the US Department of Agriculture, including animal health and livestock vaccine research. | Talk Wed Mar 10 09:10 |
Vaccinate Your Family Washington, DC | |
Non-profit advocating for on-time vaccination for people of all ages in the US. | Talk Wed Mar 10 14:40 Navigating the US Vaccine Policy Landscape 2027 Current US vaccine policy questions, including measles elimination status, compensation for COVID-19 vaccine injuries and legal liability for vaccine makers. |
Swiss centre of expertise in adjuvants and vaccine formulation that develops adjuvants and supplies them at GMP grade under open-access terms. | Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. Supply, safety & accessInfectious disease & AMR |
Bio-Manguinhos/Fiocruz Rio de Janeiro, Brazil | |
Vaccine and biopharmaceutical manufacturing institute of Brazil's Oswaldo Cruz Foundation, supplying the national immunization program. | |
PAHO Washington, DC | |
Pan American Health Organization, the World Health Organization's regional office for the Americas, running regional vaccine procurement and immunization programs. | |
Africa CDC Addis Ababa, Ethiopia | |
Africa Centres for Disease Control and Prevention, the African Union's public health agency for disease surveillance, outbreak response and immunization. | Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. Infectious disease & AMR Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. Clinical & preclinical developmentSupply, safety & access |
UK Health Security Agency (UKHSA) London, United Kingdom | |
UK agency that plans for, prevents and responds to health threats, providing scientific and operational leadership nationally and globally. | Booth Exhibiting at Booth 317 |
US association of physician groups that practise coordinated, value-based care. | Panel Wed Mar 10 10:10 Fireside chat: Navigating Dual Guidelines & State-by-State Variance How doctors and nurses cope when state, federal and medical society vaccination schedules disagree. |
U.S. coalition, formed in 2025, that brings One Health experts together to build consensus and propose federal policy on antimicrobial resistance. | Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. |
Brighton Collaboration Decatur, GA | |
Global scientific network, part of the Task Force for Global Health, setting standard case definitions for vaccine safety research. | Talk Wed Mar 10 09:10 |
DCVMN Nyon, Switzerland | |
Alliance of vaccine manufacturers in developing countries working to supply quality vaccines at affordable prices. | Talk Wed Mar 10 16:40 Beyond the IP Blueprint: Operationalizing Deep Know-How and End-to-End Technology Transfer How vaccine makers in developing countries absorb technology transfers through trained workforces and plant-floor training, not only licensed patents and documents. |
Professional association of Florida pediatricians advocating for child health, including immunization. |
Instantly find 20 buyers from public-health bodies and non-profits
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress 2027 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction